Episodes
Thursday Feb 22, 2018
E10: Abatacept in RA-ILD
Thursday Feb 22, 2018
Thursday Feb 22, 2018
Quick podcast tonight reflecting the Rheumatology Journal Club (@RheumJC) discussion! I joined as they discussed the use of abatacept in patients with rheumatoid arthritis who develop ILD. It's our first observational trial, so it's ripe for critique! Find the original paper here.
Wednesday Feb 21, 2018
E9: Rituximab in Myositis - The RIM Trial
Wednesday Feb 21, 2018
Wednesday Feb 21, 2018
This week we'll discuss a randomized controlled-ish trial, the RIM study. It pits rituximab against placebo as well as... rituximab? We'll talk about how their design convincingly demonstrated that ritixan does not have a benefit over placebo for 8 weeks, but may or may not work after that. Find the trial itself here.
Sunday Feb 11, 2018
E8: Mepolizumab or Placebo for EGPA
Sunday Feb 11, 2018
Sunday Feb 11, 2018
This week we'll discuss a recent trial on mepolizumab - and IL-5 inhibitor - for eosinophilic granulomatosis with polyangiitits. Find the paper here and be sure to follow us on twitter @JBRheum!
Sunday Feb 04, 2018
E7: The ALMS Trial - MMF vs CYC for Lupus Nephritis
Sunday Feb 04, 2018
Sunday Feb 04, 2018
Today we'll be discussing the ALMS trial, which pitted cellcept against cyclophosphamide. It's a good trial that has had profound influences on our practice and well worth a read. Access the paper itself here.